Literature DB >> 19708975

The role of EUTox in uremic toxin research.

Raymond Vanholder1, Omar Abou-Deif, Angel Argiles, Ulrich Baurmeister, Joachim Beige, Peter Brouckaert, Philippe Brunet, Gerald Cohen, Peter Paul De Deyn, Tilman B Drüeke, Danilo Fliser, Griet Glorieux, Stefan Herget-Rosenthal, Walter H Hörl, Joachim Jankowski, Achim Jörres, Ziad A Massy, Harald Mischak, Alessandra F Perna, Juan Mariano Rodriguez-Portillo, Goce Spasovski, Bernd G Stegmayr, Peter Stenvinkel, Paul J Thornalley, Christoph Wanner, Andrzej Wiecek.   

Abstract

In this publication, we review the activities of the European Uremic Toxin Work Group (EUTox) in the field of uremic toxin research. Founded in 1999 under the umbrella of the European Society of Artificial Organs (ESAO), and active since 2000, this group focuses essentially on questions related to solute retention and removal during chronic kidney disease, and on the deleterious impact of those solutes on biological/biochemical systems. As of January 1, 2009, the group had met 28 times; it organized the third meeting, "Uremic Toxins in Cardiovascular Disease," which took place in October 2008 in Amiens, France. The current group is composed of 25 members belonging to 23 European research institutions. As of November 1, 2008, in total 69 papers had been published to which at least two different research groups belonging to EUTox have contributed in a collaborative effort. Of these, 40 papers were on original research and eight were specific EUTox reviews or position statements. A website (http://www.eutox.info) summarizes all relevant information concerning the work group. EUTox also developed an interactive uremic toxin database, where concentrations of known toxins are displayed, to be used by researchers in the field. In the future, EUTox intends to continue its focus on bench to bedside research with specific consideration of proteomics, metabonomics, secretomics, and genomics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708975     DOI: 10.1111/j.1525-139X.2009.00574.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  10 in total

1.  Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles.

Authors:  Sahir Kalim; Ron Wald; Andrew T Yan; Marc B Goldstein; Mercedeh Kiaii; Dihua Xu; Anders H Berg; Clary Clish; Ravi Thadhani; Eugene P Rhee; Jeffrey Perl
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-14       Impact factor: 8.237

Review 2.  Improving Clearance for Renal Replacement Therapy.

Authors:  Seolhyun Lee; Tammy L Sirich; Timothy W Meyer
Journal:  Kidney360       Date:  2021-07

3.  Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.

Authors:  Sanjay K Nigam; Wei Wu; Kevin T Bush; Melanie P Hoenig; Roland C Blantz; Vibha Bhatnagar
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-21       Impact factor: 8.237

Review 4.  Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

Review 5.  Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico.

Authors:  Maria Eleni Roumelioti; Thomas Nolin; Mark L Unruh; Christos Argyropoulos
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

6.  Cross-sectional examination of metabolites and metabolic phenotypes in uremia.

Authors:  Sahir Kalim; Clary B Clish; Joseph J Deferio; Guillermo Ortiz; Alexander S Moffet; Robert E Gerszten; Ravi Thadhani; Eugene P Rhee
Journal:  BMC Nephrol       Date:  2015-07-07       Impact factor: 2.388

Review 7.  Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.

Authors:  Christos P Argyropoulos; Shan Shan Chen; Yue-Harn Ng; Maria-Eleni Roumelioti; Kamran Shaffi; Pooja P Singh; Antonios H Tzamaloukas
Journal:  Front Med (Lausanne)       Date:  2017-06-15

Review 8.  Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology.

Authors:  Linda Yaker; Saïd Kamel; Jérôme Ausseil; Agnès Boullier
Journal:  Toxins (Basel)       Date:  2020-12-21       Impact factor: 4.546

9.  Numerous protein-bound solutes are cleared by the kidney with high efficiency.

Authors:  Tammy L Sirich; Pavel A Aronov; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  Kidney Int       Date:  2013-05-01       Impact factor: 10.612

10.  A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.

Authors:  Sahir Kalim; Clary B Clish; Julia Wenger; Sammy Elmariah; Robert W Yeh; Joseph J Deferio; Kerry Pierce; Amy Deik; Robert E Gerszten; Ravi Thadhani; Eugene P Rhee
Journal:  J Am Heart Assoc       Date:  2013-12-05       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.